---
$id: https://graph.org.ai/products/commodity/51434811
$type: Product
source: UNSPSC
code: "51434811"
title: "Utibaprilat"
class: "51434800"
classTitle: "Antihypertensive drugs, synthesized"
family: "51430000"
familyTitle: "Antihypertensive drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Utibaprilat

**UNSPSC Code**: 51434811
**Class**: [Antihypertensive drugs, synthesized](Antihypertensive drugs, synthesized.mdx)
**Family**: [Antihypertensive drugs](../Antihypertensive drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an ace inhibitor, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier KN82541NHV. European Medicines Agency schedules Utibaprilat in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00001MIG. Utibaprilat generally arises in the molecular formula C20H27N3O5S. The term UTIBAPRILAT is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 6, no, 3 1992, list 32.) UTIBAPRILAT is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule utibaprilat under HS 29349990 and SITC 51579. As of Q4 2014, UTIBAPRILAT remains the US FDA Preferred Term for this commodity. Utibaprilat bears US NLM identifiers UMLS ID C0950771 and NCI Concept Code C72914. SMILES: S1C(=NN(C1C(=O)O)C(=O)C(NC(CCc1ccccc1)C(=O)O)C)C(C)(C)C.

